Clinical Translation Acceleration Program 2026 Annual Project

Listed on GrantGunner. Last checked 4 Oct 2026.

About this grant

The Beijing Institute of Stem Cells and Regenerative Medicine has launched a clinical translational application research program, funding proof-of-concept, preclinical, and clinical studies in areas such as stem cell regenerative medicine, organoid technology, and new drug development. It implements a phased, milestone-based rolling funding mechanism, with a maximum grant of 10 million yuan per project.

Browse all open grants

More grants from Beijing Institute of Stem Cell and Regenerative Medicine